Dr Reddy’s launches Avastin biosimilar in India
Dr Reddy’s Laboratories enters a $31m market with the launch of Versavo, a biosimilar of Roche’s Avastin in India, indicated for several types of cancer.
Dr Reddy’s Laboratories enters a $31m market with the launch of Versavo, a biosimilar of Roche’s Avastin in India, indicated for several types of cancer.
Regeneron receives FDA approval on its Eylea pre-filled syringe injection after a CRL last year requesting additional data.